TrialThe oncologist2018

Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.

George A Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.